Investec Bank Plc has filed a Form 8.5 disclosure revealing significant trading activity in Advanced Medical Solutions Group Plc ordinary shares on 21st September 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status acting in a client-serving capacity.
Investec Bank Plc holds a dual role in relation to Advanced Medical Solutions Group, serving as both advisor and joint broker to the medical solutions company.
The filing confirms that Investec purchased a total of 1,240,174 ordinary shares in Advanced Medical Solutions Group during the dealing period on 21st September 2026.
Those purchases were executed at prices ranging from a low of 281.5 pence per unit to a high of 282.25 pence per unit across the transaction.
On the selling side, Investec recorded disposals totalling 1,172,056 ordinary shares, with prices ranging between 282 pence and 282.25 pence per unit.
The volume of shares traded across both purchases and sales highlights the scale of Investec’s market activity in Advanced Medical Solutions Group stock on that date.
No cash-settled derivative transactions, stock-settled derivatives, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or other formal or informal understandings that could constitute an inducement to deal or refrain from dealing.
The bank also confirmed no agreements exist relating to voting rights or future acquisition and disposal of relevant securities linked to any derivative instruments.
The disclosure was formally submitted on 22nd September 2026, with contact for the filing attributed to Priyali Bhattacharjee at Investec Bank Plc.
Under the Takeover Code, all Rule 8 public disclosures of this nature are required to be submitted to a recognised Regulatory Information Service for transparency purposes.
